Rare Childhood Disease Helping to Unravel How PTEN Mutations Affect Prostate and Other Cancers

Rare Childhood Disease Helping to Unravel How PTEN Mutations Affect Prostate and Other Cancers
Researchers have found a link between the rare childhood disease, called Fanconi anemia, and a major cancer gene, known as PTEN, that is often mutated in brain, uterine, and prostate cancers. In the study, "The PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair," they show that Fanconi anemia proteins and PTEN work together to repair DNA damage caused by DNA crosslinking agents, a class of drugs that includes some chemotherapies (such as the platinum-based chemotherapy, cisplatin). Their finding suggests that Fanconi anemia proteins may help predict which cancer patients will benefit from such treatments. The study was published in <
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *